Thus, the effects of EGFR on Aβ, neuroinflammation, and cognitive function have spurred growing interest in the potential repurposing of EGFR inhibitors used as anti-cancer drugs for the treatment of AD (Mansour et al., 2021c). The gene discussed is EGFR; the disease is Alzheimer disease.